General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0UJMPA
ADC Name
BA-1302
Synonyms
BA 1302; BA-1302; BA1302
   Click to Show/Hide
Organization
Shandong Boan Biotechnology Co., Ltd.; Luye Pharma Group Ltd.
Drug Status
Phase 1
Indication
In total 4 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Lung cancer
Phase 1
Clinical Trial
Melanoma
Phase 1
Clinical Trial
Pancreatic cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
4
Antibody Name
Undisclosed
Antigen Name
Melanotransferrin (MELTF)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Conjugate Type
Undisclosed
Combination Type
BNLD11